0
     

Report Added
Report already added
Skin Grafting Device Market - Growth, Trends, Covid-19 Impact, and Forecasts (2021 - 2026)

Skin Grafting Device Market - Growth, Trends, Covid-19 Impact, and Forecasts (2021 - 2026)

The Skin Grafting Device Market is expected to register a CAGR of 5.3% during the forecast period.

Recent studies published by the Asia Pacific Blood Network 2020 and Transfusion Medicine Reviews Journal 2020, stated that relatively there is a higher risk for transmission of viruses such as COVID-19 via blood. In addition, according to a research article by Timothy Michael Noblet et al., published in Burns Journal 2021, globally, in the current scenario of COVID-19 the harvesting skin grafts with a pneumatic dermatome, there is a significant risk of droplet contamination to the operators and the immediate environment of the patient.

Furthermore, the study results also suggested that it is reasonable to use full high-risk personal protective equipment (PPE) when harvesting skin grafts, and the number of people within 1 meter of the harvest site is kept to the absolute minimum, ideally a single surgeon where possible.

Skin grafting is a novel technological advancement to surgical procedure, which covers skin replacement from the healthy area of skin and providing coverage for wound area. Skin grafting is majorly used in different wound indications, such as deep burns, skin cancer, injury, or reconstructive surgeries. Increasing prevalence and incidences of burns injuries, leg ulcers, including pressure and diabetic foot ulcer, and skin infections leading to prolonged hospitalization are influencing the demand in the skin grafting device market.

Moreover, technological innovations in dermatomes, such as development of electric and air dermatomes, and increased precision are some of key factors expected to boost the market for skin grafting system. Rising demand for skin grafts is another major factor propelling the market growth.

For instance, in May 2017, Exsurco Medical, Inc., launched new wound debridement and skin grafting medical device designed for use in burn and trauma centers. The new Amalgatome SD is a revolutionary break-through in combining skin grafting and wound debridement technology in an industry. By using one device for multiple procedures (auto grafting and/or excision), the Amalgatome SD helps those who are in critical need of the healing power of skin.

Care and treatment procedures have taken a more comprehensive approach, which not only focuses on recovery from injuries but also on improvement in long-term function. Owing to this trend, the demand for skin grafts and other skin substitutes in treatment and management of acute wounds is rising at a steady pace. Skin grafting procedures are majorly used on partial and full thickness burns, and they have an important role in treatment of such injuries. Skin grafting can be biological or synthetic in nature.

Presence of non-profit organizations, such as the British Burn Association and the Canadian Association of Burn Nurses, which aim to provide and propagate knowledge on best treatment and rehabilitation following a burn injury, is also increasing awareness levels among people. However, this market growth may be hampered, owing to the factors, such as poor healthcare accessibility in low income countries and lack of advanced healthcare infrastructure.

Key Market Trends

Burns Segment is Expected to Hold Significant Market Share During the Forecast Period

The major factors driving the burns segment growth include rising incidence of such injuries, high demand for skin grafts, growing awareness regarding treatment options, and increasing technological advancements. Increasing awareness among patients regarding various treatment and care options available is a key factor driving the market.

Globally, during the SARS-Cov-2 (COVID-19) pandemic 2020, the majority of healthcare systems focused their approach on disease prevention. The main strategies adopted to prevent disease spread through the use of personal protective equipment (PPE), social distancing, testing and quarantine of infected cases, and rationalizing health care services to prioritize intensive care resources.

During the COVID-19 pandemic 2020, globally, there was a significant impact in providing burns services by healthcare providers. For instance, according to a research study by Azzam Farroha., published in Burns Journal 2020, it was found that in the United Kingdom, the number of burn cases reported to the emergency department was decreased by 33% during the lockdown period (March – May) and the number of cases referred from other healthcare facilities to centre was decreased by 42%.

According to the World Health Organization (WHO) 2018 Factsheet, worldwide, every year, an estimated 180,000 deaths are caused by burns. Majority of the burn injuries occur in low- and middle-income countries and almost two thirds occur in the Africa and South-East Asia regions. Non-fatal burn injuries are a leading cause of morbidity. Burns occur mainly in the home and workplace.

The different treatment and care options for such injuries include advanced dressings, traditional care products, and biologics. Biologics, including skin grafts, are also widely used. The presence of a wide array of products for burn care in the market is encouraging healthcare professionals, such as surgeons, physicians, and nurses, to increase the usage of such treatment options.

Favorable government initiatives, such as reimbursement policies that cover almost 70%-100% of the treatment cost, have enabled patients to opt for advanced burn care treatment. The presence of non-profit organizations, like the American Burn Association (ABA), and government organizations, such as World Health Organization (WHO), also contributes toward increasing awareness levels.

For instance, as per Health, Medical and Family Welfare Department 2020 report, in India, the Government of Telangana providing cashless and qualitative treatment for burns and debridement and skin grafting for avulsion injuries to the State Government Employees under Health, Medical and Family Welfare Department. Thus, considering above mentioned factors it is expected to show significant growth over the forecast period.

North America is Considered to be the Most Lucrative Regional Market for Skin Grafting Devices

The major factors driving the market growth in the North American region include high demand for skin grafts and substitutes and increasing incidence of burns are expected to drive the market for skin grafting devices. Moreover, the presence of key market players in this region, focusing on strategic initiatives, such as the launch of new products and mergers and acquisitions, is expected to create lucrative growth opportunities.

According to a research article by Juan P. Barret et al., published in Burns Journal, in the United States during the COVID-19 pandemic 2020, the University of Iowa took initiatives in providing burn services such as electronic communication platforms for communication and telemedicine services to communicate with both clinic and hospitals. Even though during the COVID pandemic, the burn centers in the United States maintained intense and meticulous precautions with great discipline. Adding to that, burn patients who were COVID-positive were successfully managed as part of the COVID-positive cohort.

According to the American Burn Association (ABA) National Burn Repository 2019 reports, flame burns are still the majority of injuries in the United States with 41%, followed by scald injuries at 31% and electrical burn injuries at 3.6%, respectively. Burns in children less than 5 years of age tend to be scald injuries, with increasing flame-related burns as age increases.

The Asia-Pacific market is anticipated to witness the fastest growth over the forecast period. According to the World Health Organization 2018 Factsheet, the incidence of burn injuries that require immediate medical care is approximately 20 times higher in the Western Pacific Region in comparison to that in the Americas.

Furthermore, an increase in the incidence of burn injuries and chronic wounds is a major factor boosting the market in this region. In addition, the increasing R&D activities by prominent market players for the introduction of innovative products are expected to fuel the market growth over the forecast period.

Competitive Landscape

The market for skin grafting devices is moderately competitive in nature. The market players are actively involved in product innovations and technological advancements to sustain their position in the market. Some of the key market players include Zimmer Biomet, B. Braun Melsungen AG, Integra Lifesciences Corporation, Exsurco Medical, Inc., Rudolf Storz GmbH.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidences of Burn Injuries and Wounds
4.2.2 Technological Innovations in Dermatomes
4.3 Market Restraints
4.3.1 Poor Healthcare Accessibility in Low Income Countries
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Dermatome
5.1.1.1 Electric Dermatome
5.1.1.2 Drum Dermatome
5.1.1.3 Other Products
5.1.2 Wound Debridement Devices
5.1.3 Other Devices
5.2 By Type
5.2.1 Autograft
5.2.2 Allograft
5.3 By Wound Type
5.3.1 Burns
5.3.2 Chronic wounds
5.3.3 Surgical Wounds
5.3.4 Traumatic Wounds
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 B. Braun Melsungen AG
6.1.2 Desoutter Medical
6.1.3 Exsurco Medical Inc.
6.1.4 Integra LifeSciences Corporation
6.1.5 Rudolf Storz
6.1.6 Zimmer Biomet
6.1.7 Smith & Nephew
6.1.8 Organogenesis, Inc
6.1.9 Tissue Regenix
6.1.10 Nouvag AG
6.1.11 Avita Medical
6.1.12 Ishago Surgical
6.1.13 Mallinckrodt (Stratatech Corporation)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Report Title: Skin Grafting Device Market - Growth, Trends, Covid-19 Impact, and Forecasts (2021 - 2026)


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 United Arab Emirates Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 United Arab Emirates Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Ukraine Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Ukraine Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline